Trusted News Discovery Since 2008
{{/content}}
Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News
Video Credit: Oneindia
Published on June 22, 2021 - Duration: 02:02s
Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News
Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI).
The development comes nearly five months after Covaxin was authorised for emergency usage in the country.
#Covid19 #BharatBiotech #Covaxin
You are here
💡 newsR Knowledge: Other News Mentions
Bharat Biotech
Indian multinational biotechnology company and vaccine manufacturer
Credit: IndiaTimes - Published 5 days ago
COVID-19
Contagious disease caused by SARS-CoV-2
A 22-year-old cricketer and biotechnology student, Tauseef Ali Farooqui, arrested under UAPA for expressing intent to join IS. Mental health issues during Covid..
Credit: IndiaTimes - Published 12 hours ago
The government will end routine COVID testing for hospital patients discharged into care homes from April 1.
Credit: Sky News - Published 4 days ago
Exactly four years ago today, Boris Johnson announced the UK's first COVID lockdown, ordering people to "stay at home".
Credit: Sky News - Published 1 week ago
Related videos from verified sources
Haryana CM to farmers: We are patient but don't cross limits| Farmer Protest| Oneindia News 02:36
Video credit: Oneindia - Published on June 30, 2021
Covaxin neutralizes both Alpha & Delta variants of coronavirus: US Institute| Oneindia News 02:11
Video credit: Oneindia - Published on June 30, 2021
Brazil suspends Covid-19 vaccine deal with India| Bharat Biotech denies any wrongdoing|Oneindia News 02:00
Video credit: Oneindia - Published on June 30, 2021